JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.19B |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$680M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$663M |
| 5 |
SLB Ltd
SLB
|
+$522M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$2.45B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1.03B |
| 3 |
McKesson
MCK
|
+$941M |
| 4 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$875M |
| 5 |
Coca-Cola
KO
|
+$711M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.24% |
| 2 | Technology | 11.01% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Chemed
CHE
$7.02B
| $6.27M | ﹤0.01% |
44,432
-81,417
| -65% | -$11.3M |
|
1977
CALL
GSK
GSK
$101B
| $6.25M | ﹤0.01% |
116,000
-5,440
| -4% | -$298K |
|
1978
ACI Worldwide
ACIW
$5.42B
| $6.23M | ﹤0.01% |
321,426
-2,373
| -0.7% | -$45K |
|
|
ACOR
1979
DELISTED
Acorda Therapeutics
ACOR
| $6.22M | ﹤0.01% |
2,484
-43
| -2% | -$128K |
|
|
ANAT
1980
DELISTED
American National Group, Inc. Common Stock
ANAT
| $6.21M | ﹤0.01% |
50,894
-4,547
| -8% | -$525K |
|
1981
iShares MSCI Indonesia ETF
EIDO
$484M
| $6.2M | ﹤0.01% |
234,558
-3,229
| -1% | -$83.2K |
|
|
CALY
1982
Callaway Golf Company
CALY
$2.94B
| $6.2M | ﹤0.01% |
533,891
-12,238
| -2% | -$136K |
|
1983
iShares S&P Small-Cap 600 Value ETF
IJS
$8.43B
| $6.18M | ﹤0.01% |
99,076
-2,164
| -2% | -$133K |
|
1984
DNOW Inc
DNOW
$2.95B
| $6.18M | ﹤0.01% |
288,342
+67,088
| +30% | +$1.34M |
|
1985
PUT
Teck Resources
TECK
$31.3B
| $6.17M | ﹤0.01% |
342,000
| – | – |
|
1986
B&G Foods
BGS
$299M
| $6.16M | ﹤0.01% |
125,173
+44,183
| +55% | +$2.12M |
|
1987
Cenovus Energy
CVE
$56.5B
| $6.15M | ﹤0.01% |
427,702
-104,787
| -20% | -$1.5M |
|
1988
Olin
OLN
$2.17B
| $6.15M | ﹤0.01% |
299,552
+232,376
| +346% | +$5M |
|
1989
PennyMac Financial
PFSI
$4.13B
| $6.13M | ﹤0.01% |
360,125
+125
| +0% | +$1.9K |
|
|
PFC
1990
DELISTED
Premier Financial Corp. Common Stock
PFC
| $6.12M | ﹤0.01% |
274,054
+109,904
| +67% | +$2.37M |
|
|
FSP
1991
Franklin Street Properties
FSP
$46.5M
| $6.11M | ﹤0.01% |
484,846
+1,316
| +0.3% | +$16.6K |
|
|
MDP
1992
DELISTED
Meredith Corporation
MDP
| $6.1M | ﹤0.01% |
117,380
+166
| +0.1% | +$8.86K |
|
|
SBY
1993
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $6.1M | ﹤0.01% |
347,953
+69,364
| +25% | +$1.27M |
|
|
AMRI
1994
DELISTED
Albany Molecular Research Inc
AMRI
| $6.07M | ﹤0.01% |
367,827
+266,138
| +262% | +$3.94M |
|
1995
Expeditors International
EXPD
$24.3B
| $6.07M | ﹤0.01% |
117,866
-917,088
| -89% | -$46.4M |
|
1996
Group 1 Automotive
GPI
$3.13B
| $6.07M | ﹤0.01% |
94,948
+47,375
| +100% | +$2.79M |
|
1997
abrdn Physical Gold Shares ETF
SGOL
$7.42B
| $6.06M | ﹤0.01% |
473,050
-690
| -0.1% | -$8.96K |
|
1998
CALL
IBM
IBM
$223B
| $6.06M | ﹤0.01% |
39,924
-23,535
| -37% | -$3.57M |
|
|
RPT
1999
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $6.06M | ﹤0.01% |
323,325
+14,343
| +5% | +$277K |
|
2000
Pacira BioSciences
PCRX
$924M
| $6.05M | ﹤0.01% |
176,725
+82,701
| +88% | +$3.24M |
|
Similar funds
JP Morgan Chase's Q3 2016 Portfolio in Review
As of Q3 2016, JP Morgan Chase held 5,175 positions worth $406B, up 1.3% from $401B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase withdrew a net $15.4B in Q3 2016, closing 607 positions and reducing 1,910 holdings. Its most notable exit was COLUMBIA PIPELINE GROUP IN COM STK (DE), an estimated $395M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Patheon N.V. worth $91.3M.
- JP Morgan Chase's largest Q3 2016 buy was Patheon N.V.: 3,082,044 shares worth $91.3M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $4B increase.
- JP Morgan Chase's biggest Q3 2016 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $2.45B.
- JP Morgan Chase fully exited COLUMBIA PIPELINE GROUP IN COM STK (DE) in Q3 2016, selling an estimated $395M.
- JP Morgan Chase's ten largest holdings make up 18% of its $406B portfolio in Q3 2016.
- JP Morgan Chase opened 337 new positions and closed 607 in Q3 2016.
- JP Morgan Chase's portfolio value rose 1.3% quarter-over-quarter to $406B.
Based on JP Morgan Chase's 13F filing for Q3 2016, filed 4 Nov 2016.